Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
BOSTON Pfizer today said it would change its direct-to-consumer advertising of prescription medicines and make its practices consistent with the “Guiding Principles” put forth by the Pharmaceutical Researchers and Manufacturers Association on Aug. 2.
The New York-based drug company said it would seek to better educate physicians about new medicines prior to advertising them on TV and in print, as well as include language in ads about alternate treatments.
Specifically, Pfizer said it intends to “fundamentally change our approach to communicating risk and benefit information to improve educational value, while continuing to motivate.”
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in